A non-randomised study investigating the use of multi-parametric magnetic resonance imaging (mpMRI) to develop imaging biomarkers that will be used to escalate dose to subregions of tumour that are resistant to radiation therapy

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Registry
Year 2026
This article has no abstract
Epistemonikos ID: d503bf0acb34920c5908c2f8f6d35038de86b5bd
First added on: Oct 10, 2026